<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Defects in apoptotic machinery vary among individual <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, and the efficacy of chemotherapy in killing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells depends on the successful induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>This study tested the hypothesis that the intrinsic ability of a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell's natural resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> would indicate its ability in resistance to chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>Four widely studied human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines, SW480, HT-29, LoVo and Caco-2, were examined for their apoptotic fates in spontaneous cultures for up to 6 days using flowcytometry </plain></SENT>
<SENT sid="3" pm="."><plain>Chemoresponse of these cells was tested against anti-<z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> drugs <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU) and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> (OXP) at different peak plasma concentrations (PPCs) using <z:chebi fb="0" ids="53233">MTT</z:chebi> assay </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> analyses demonstrated that, from Day 2 to Day 6 in spontaneous cultures, SW480 and HT-29 lines showed resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by having much less average early and late apoptotic cells than LoVo and Caco-2 lines with differences of 3.2- to 5.2-fold </plain></SENT>
<SENT sid="5" pm="."><plain>Interestingly, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-resistant SW480 and HT-29 exhibited higher chemoresistance to both 5-FU (P &lt; 0.01 at 5×, 10×, and 50× PPC) and OXP (P &lt; 0.01 at 5× and 10× PPC, and P &lt; 0.05 at 50× PPC) than LoVo and Caco-2 </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> cells' natural resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> is an intrinsic ability that correlates with resistance to chemotherapeutic drugs 5-FU and OXP </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> cells' natural apoptotic phenotypes may help predict the outcome of chemotherapy in <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
</text></document>